Participate in Alzheimer's Research

(Scroll Down↓ For More)

In Person (non clinical trial) Research


HOPE - Actively Enrolling

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: ngullott@bu.edu

 

Time Commitment  - The HOPE study takes place yearly with an in-person visit at one of two study locations in Massachusetts.  Each year's visit will take approximately 2 days to complete 

Location - Participation can occur at either Boston University Medical Center, or Boston University Neurology Associates at Wingate Residences at Needham.

Learn more HERE

 

 

Alzheimer Disease Clinical Trials


Goal- This study is designed to find out whether the investigational drug (or “study drug”) LY3314814 can slow down the decline in memory and mental functioning.

Time Commitment- About 3 years

Location: Boston University Medical Center, and other locations across the country.

Eligibility- Male and female participants between the ages of 55 and 85. Learn more about specific eligibility requirements HERE.

DAY BREAK- Actively Recruiting

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: Ngullott@bu.edu

 

 


Goal - The purpose of this study is to evaluate the safety, tolerability, and efficacy of BAN2401 from subjects with Early Alzheimer’s Disease. 

Time Commitment - 18 months

Location - Boston University Medical Center, and 67 other locations across the country. See all the locations HERE

Eligibility - Male and female participants between the ages of 50 and 90. Learn more about specific eligibility requirements at the study website HERE.

BAN2401 Clinical Trial - Ongoing

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: Ngullotti@bu.edu

 


Goal - To test whether Solanezumab can be used as a neuroprotector to slow the cognitive and functional decline of Alzheimer's Disease. 

UPDATE: Research is ongoing, but the study is no longer enrolling new participants

The Expedition 3 Trial - Ongoing, but no longer enrolling

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: ngullott@bu.edu


Goal - A Phase 2 multi-center, randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer’s Disease. 

Time Commitment - 18 visits over 13 months

Location - Boston University Alzheimer's Disease Center or 49 other locations around the United States. Find a site HERE

Eligibility - Men or women 55-85 years of age with mild to moderate Alzheimer’s disease receiving donepezil (Aricept®) or rivastigmine transdermal system (Exelon® Patch). Must read and understand English and have an eligible informant or study partner (caregiver). 

Learn more HERE

The NOBLE Study - Ongoing, but no longer enrolling

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: ngullott@bu.edu

 


Goal -  To evaluate the imaging capabilities and the safety of 18F-AV-1451 in cognitively healthy volunteers, subjects with mild cognitive impairment, and subjects with Alzheimer’s disease.

Time Commitment - 1 in person visit

Location - Boston University Medical Center, and 28 other locations across the country. See all the locations HERE

Eligibility - Inquire HERE for full eligibility criteria

Brain Imaging in Cognitively Healthy, MCI and AD Subjects - Actively Enrolling

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: ngullott@bu.edu


Time Commitment - In person visits every 4 weeks for 3 years

Location - On site at Boston University Medical Center or over 70 centers across the United States, Canada, and Australia.  See all the locations HERE

Eligibility - Women and men 65-85 years old with normal thinking and memory abilities. Study partner able to answer questions about your memory once a year required. 

Learn more HERE

The A4 Study - Actively Enrolling

Recruitment Coordinator: Nicole Gullotti

Phone: 617-414-1077

Email: ngullott@bu.edu